Literature DB >> 15554079

Clinical impact of inspiratory muscle impairment in sarcoidosis.

Pierre Brancaleone1, Thierry Perez, Sophie Robin, Remi Neviere, Benoît Wallaert.   

Abstract

BACKGROUND AND AIM OF THE WORK: We evaluated the clinical consequences of inspiratory muscle impairment on exercise tolerance and quality of life in 34 sarcoid patients compared with 19 controls.
METHODS: We measured pulmonary function tests, inspiratory muscle strength by maximal inspiratory pressure (PImax) and inspiratory muscle endurance (IME) by an incremental threshold loading test. IME was defined by the maximal sustainable pressure for 2 minutes (Plim2) and Plim2/PImax. Cycloergometer incremental exercise testing was performed in all patients. Health-related quality of life (HRQOL) was assessed by the SF-36 questionnaire in comparison with scores of 116 French controls. Dyspnea was assessed by the Modified Dyspnea Index (MDI).
RESULTS: All SF-36 subscales were lower in sarcoid patients (p < 0.05). PImax% pred was similar in both groups whereas IME was markedly lower in sarcoid patients (p < 0.0001). Plim2 correlated with MDI (r = 0.44; p = 0.01) and SF-36 scales Physical Functioning (PF) (r = 0.42; p = 0.034) and Physical Role (PR) (r = 0.63; p = 0.0016). Plim2/PImax correlated with SF-36 subscales: PR (r = 0.62), vitality (VT) (r = 0.56) and social functioning (SF) (r = 0.39). Plim2 (r = 0.639; p = 0.0002) and Plim2/PImax (r = 0.36; p = 0.036) correlated with peak exercise tidal volume (V(T)max) but not with VO2max.
CONCLUSIONS: Inspiratory muscle impairment was related to physical HRQOL scores but not to exercise tolerance, although it could impair exercising V(T) through an incipient inspiratory muscle fatigue.

Entities:  

Mesh:

Year:  2004        PMID: 15554079

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  4 in total

Review 1.  Respiratory and lower limb muscle function in interstitial lung disease.

Authors:  Marios Panagiotou; Vlasis Polychronopoulos; Charlie Strange
Journal:  Chron Respir Dis       Date:  2016-01-14       Impact factor: 2.444

Review 2.  Patient reported outcome measures (PROMs) in sarcoidosis.

Authors:  Rikke Flor Thunold; Anders Løkke; Adam Langballe Cohen; Hilberg Ole; Elisabeth Bendstrup
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Relationship of pectoralis muscle area and skeletal muscle strength with exercise tolerance and dyspnea in interstitial lung disease.

Authors:  Krauspenhar Merola Pietro; Gass Ricardo; Gustavo Paulus Nenê Dorneles Rui; Basso Gazzana Marcelo; Ferreira Gazzoni Fernando; Hochhegger Bruno; Verges Samuel; C Berton Danilo
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

4.  High-intensity resistance training in newly diagnosed sarcoidosis- an exploratory study of effects on lung function, muscle strength, fatigue, dyspnea, health-related quality of life and lung immune cells.

Authors:  Susanna Kullberg; Natalia V Rivera; Maria J Eriksson; Johan Grunewald; Anders Eklund
Journal:  Eur Clin Respir J       Date:  2020-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.